Eli Lilly (LLY) total assets
Eli Lilly (LLY) had total assets of $112.48B at the end of fiscal 2025 (December 31, 2025). That is 42.9% higher than the $78.72B of fiscal 2024. Figures as of 17 Nov 2026, 17:17 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Total assets, fiscal 2025
- $112.48B
- Change on fiscal 2024
- +42.9%
- Growth, 5 years
- +19.3% a year
- Growth, 10 years
- +12.2% a year
- Highest on record
- $112.48Bfiscal 2025
- Lowest on record
- $27.46Bfiscal 2009
- Fiscal years on record
- 182008–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Eli Lilly total assets, in more detail
Over the five fiscal years to 2025 total assets grew at a compound 19.3% a year; over ten years the rate was 12.2% a year. Across the 18 fiscal years on record (2008–2025), the highest was $112.48B in fiscal 2025 and the lowest $27.46B in fiscal 2009.
Total assets by fiscal year
Eli Lilly total assets, year by year
| Fiscal year | Total assets | Change | Year ended |
|---|---|---|---|
| 2025 | $112.48B | 42.9% up | |
| 2024 | $78.72B | 23.0% up | |
| 2023 | $64.01B | 29.3% up | |
| 2022 | $49.49B | 1.4% up | |
| 2021 | $48.81B | 4.7% up | |
| 2020 | $46.63B | 18.7% up | |
| 2019 | $39.29B | 10.5% down | |
| 2018 | $43.91B | 2.4% down | |
| 2017 | $44.98B | 15.9% up | |
| 2016 | $38.81B | 9.1% up | |
| 2015 | $35.57B | 2.0% down | |
| 2014 | $36.31B | 3.0% up | |
| 2013 | $35.25B | 2.5% up | |
| 2012 | $34.40B | 2.2% up | |
| 2011 | $33.66B | 8.6% up | |
| 2010 | $31.00B | 12.9% up | |
| 2009 | $27.46B | 6.0% down | |
| 2008 | $29.21B | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.
How to read it
It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.
Total assets at health care companies of similar size
| Company | Total assets | Fiscal year |
|---|---|---|
| Eli Lilly LLY | $112.48B | 2025 |
| Johnson & Johnson JNJ | $199.21B | 2025 |
| AbbVie ABBV | $133.96B | 2025 |
| Merck & Co MRK | $136.87B | 2025 |
| UnitedHealth Group UNH | $309.58B | 2025 |
| Novartis NVS | $110.95B | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Eli Lilly, figure by figure
- Eli Lilly market cap
- Eli Lilly revenue
- Eli Lilly earnings
- Eli Lilly earnings per share (EPS)
- Eli Lilly P/E ratio
- Eli Lilly P/S ratio
- Eli Lilly P/B ratio
- Eli Lilly free cash flow
- Eli Lilly operating margin
- Eli Lilly dividend
- Eli Lilly shares outstanding
- Eli Lilly total debt
- Eli Lilly cash on hand
- Eli Lilly return on equity (ROE)
- Eli Lilly return on invested capital (ROIC)
Eli Lilly (LLY) overview: price, valuation and scorecardAll health care companies by market value
Eli Lilly total assets: questions and answers
How large are Eli Lilly's total assets?
Eli Lilly (LLY) had total assets of $112.48B at the end of fiscal 2025 (December 31, 2025). That is 42.9% higher than the $78.72B of fiscal 2024.
What is the growth rate of Eli Lilly's total assets?
Over the five fiscal years to 2025 total assets grew at a compound 19.3% a year; over ten years the rate was 12.2% a year.
What are the highest and lowest total assets figures on record for Eli Lilly?
Across the 18 fiscal years on record (2008–2025), the highest was $112.48B in fiscal 2025 and the lowest $27.46B in fiscal 2009.
How is Eli Lilly's total assets calculated?
Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.
Fiscal years are named for the calendar year they end in.
Learn: total assets
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Eli Lilly (LLY) total assets”, data as of 17 November 2026. https://funkfolio.com/stock/LLY/total-assets
Underlying data: the company's filings with the SEC and Yahoo Finance.